期刊
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 60, 期 1, 页码 100-106出版社
OXFORD UNIV PRESS
DOI: 10.1093/jac/dkm125
关键词
fungal; mycology; drug monitoring
Background. Co-morbidity, medical and surgical interventions often cause alterations to drug plasma concentrations and pharmacokinetic parameters in critically ill patients. In the present study, we investigated parameters influencing plasma caspofungin concentrations in patients of a surgical intensive care unit (SICU). Methods: In a monocentre open study, caspofungin trough concentrations (C-24) were determined for a group of SICU patients. A linear-mixed model was then used to assess factors influencing caspofungin plasma concentrations. Results: A total of 40 SICU patients were enrolled. Age and body weight ranged from 22 to 76 years and 47 to 108 kg, respectively. All participants received a caspofungin loading dose of 70 mg and a maintenance dose of 50 mg/day. The median duration of therapy was 10 days. Caspofungin C-24 in SICU patients varied more than those determined for healthy subjects reported in previous studies (0.52-4.08 mu g/mL versus 1.12-1.78 mu g/mL). According to our model, caspofungin C24 were predicted to be significantly higher in patients with body weight < 75 kg (P = 0.019) and patients with albumin concentration > 23.6 g/L (P = 0.030). Conclusions: Our results show that body weight and albumin concentration influence caspofungin C-24 in SICU patients and should therefore be considered prognostic factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据